Hanshow Unveils Polaris Pro ESL at NRF 2024 - Redefining Retail with Full Color Sustainable Solutions
Hanshow has unveiled the breakthrough Polaris Pro series at the National Retail Federation 2024 convention in New York, fully encapsulating the company's innovative spirit and vision for "Full Color Sustainable Retail." Attendees can experience the future of retail at Booth 3365, Level 3, Javits Convention Center in NYC, from January 14 to 16.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240112503919/en/
(Photo: Business Wire)
Hanshow Polaris Pro is not simply another ESL - it represents a new frontier in retail efficiency and customer engagement with new core features that set it apart:
Elevated Screen-to-Body Ratio and Superior Multicolor Display: The Hanshow Polaris Pro series redefines adaptability in retail spaces with its advanced placement flexibility, facilitating seamless integration into diverse store layouts. A stunning visual upgrade is achieved through a significant increase in screen-to-body ratio, offering larger displays housed within sleeker bezels, and the ability to display both horizontally and vertically.
Streamlined Design and Durable Battery Life: Retailers will appreciate the unibody design of Hanshow Polaris Pro – remarkably 37% thinner than traditional electronic shelf labels. This slim profile is combined with a thinner and user-replaceable battery that boasts up to a decade of life, ensuring sustained performance and reducing maintenance efforts.
Intelligent In-Store Management Efficiency and Shopping Experience: With precise product positioning and an innovative one-second flashing light feature, Hanshow Polaris Pro guarantees that both staff and customers can locate products with unprecedented ease. This accelerates inventory management and enhances the shopping experience, culminating in elevated operational productivity.
Millisecond-Level Price Synchronization and Reliability: The Hanshow Polaris Pro series’ capability for millisecond-level timed updates synchronizes effortlessly with POS systems, facilitating immediate and accurate pricing across an entire retail network. This technology is robust enough to maintain functionality, ensuring consistent operation even during unforeseen network or power outages.
Eco-Friendly Manufacturing: Embodying Hanshow’s commitment to sustainability, the Polaris Pro is produced using clean-energy powered automation, reducing carbon footprint and maintaining high consistency and quality, The highly integrated design of the SiP chip lowers the number of electronic components and further reduces carbon emissions.
“Hanshow Polaris Pro isn't just a new product; it's a statement about where the retail industry can go when it embraces sustainability without compromising on functionality,” said Shiguo Hou, CEO of Hanshow. “This launch signifies our unwavering dedication to providing comprehensive, sustainable, and consumer-friendly retail solutions.”
Beyond the Hanshow Polaris Pro launch, Hanshow's NRF 2024 showcase delivered a holistic approach to retail innovation. In-store marketing and AI-driven solutions taking center stage, Hanshow demonstrates how seamlessly integrated technology can personalize customer interactions, optimize store operations, and contribute to environmental sustainability.
Hanshow is advancing its vision for a greener, more digital and more sustainable future, with a commitment to creating positive impacts within the industry and delivering exceptional value to customers. Hanshow’s dedication to continuous innovation remains unwavering, and this dedication extends to its partners, stakeholders, and the entire community whose steadfast support has been integral to the company's success. Hanshow looks to share its future and the exciting journey of upgrading the retail industry as part of this global community.
About Hanshow
Hanshow is one of the global leaders in the development and manufacturing of electronic shelf labels and digital store solutions. The company offers customers a series of customized IoT touchpoints and digital store solutions that deliver customer-centric insights. Hanshow's solutions have provided services to a vast number of stores across more than 50 countries and regions, helping them streamline operations, optimize pricing strategies, and offer consumers a more personalized experience. Learn more: www.hanshow.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240112503919/en/
Contact information
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz ® ) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 01:45:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) in adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal cancer (SCAC) who have not been previously treated with systemic chemotherapy, were published in The Lancet.1 “The publication of the POD1UM-303/InterAACT 2 trial in The Lancet is a testament to the strength of the data generated for retifanlimab in patients with inoperable locally recurrent or metastatic SCAC, a disease which until recently had seen limited innovation for decades,” said Steven Stein, M.D., Chief Medical Officer, Incyte. “SCAC can be a devastating disease, and patients often have a poor prognosis. These data supported the U.S. Food and Drug Administration (FDA) approval of Zynyz® (retifanl
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 22:30:00 EEST | Press release
Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal, but a core driver of innovation. Key milestones include a near-complete transition to natural refrigerants
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 21:45:00 EEST | Press release
Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of European enterprises, providing a framework for high performance in even the most complex, secure environments. “With about 6 million developers across Europe, users deserve infrastructure that meets them where they are,” said Varun Mohan, CEO of Windsurf. “The demand for secure AI-powered development is undeniable and by launching this GPU cluster, we aim to b
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 20:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization journey, allowing developers to focus on building engaging games, not commerce infrastructure. This SDK connects three
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 18:00:00 EEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom